Sight Diagnostics

Last updated: October 11, 2024

Yossi Pollak, Co-Founder and CEO
Yossi Pollak, Co-Founder and CEO
Israel | Funding: $123.8M (+)

Website: https://www.sightdx.com/

Sight Diagnostics aims to bring affordable, scalable and accurate blood diagnostics to the point-of-care, thereby accelerating better patient outcomes and improving healthcare for all. Sight has developed an artificial intelligence-driven platform for blood analysis and infectious disease diagnostics based on its proprietary machine-vision technology.